Shaping a future free from Alzheimer's disease
Dr. Mora Pinzon spoke to Telemundo Wisconsin about the of Alzheimer's disease treatment 'Leqembi' (lecanemab) on July 14, 2023. The medication was fully approved by the U.S. Food and Drug Administration (FDA) approved on July 6, 2023.
Dr. Carlsson spoke to multiple media outlets about lecanemab and its use in the AHEAD study at UW.
The new funding will also enable expansion of the project to identify other causes of cognitive decline and enhance the diversity of the cohort through recruitment of people from communities historically under-represented in research.
Maria Mora Pinzon, MD, MS, FACPM, has been named a 2023 faculty scholar with the NIA IMPACT Collaboratory. Dr. Mora Pinzon has been appointed to the Stakeholder Engagement Team (SET) for a one-year term through June 30, 2024. The Collaboratory is working to build pragmatic clinical trials for dementia by embedding accessible clinical trials in …
Maria Mora Pinzon, MD, MS discussed a study from Stanford University that showed a potential link between people who received a shingles vaccine and a reduced risk of developing dementia
On June 8, 2023, Wisconsin Governor Tony Evers and First Lady Kathy Evers welcomed people living with dementia and their caregivers, to dementia friendly events at the Governor’s Executive Residence.
Summer 2023 issue describes work of Dr. Chin and highlights Dr. Carlsson and Dr. Johnson
Photos from the 2023 Breaking the Silence community event.
The work of the Wisconsin Alzheimer's Institute Regional Milwaukee Office is featured in a segment on television station WTMJ-TV Milwaukee. Gina Green-Harris, MBA, director of WAI Regional Milwaukee Office, is interviewed in the segment. Green-Harris describes how the office opened in 2008 with a goal of increasing awareness, education about Alzheimer's disease and particularly its impact on communities of color.
Gina Green-Harris is chairperson of the Governor's Health Equity Council